Volitionrx (VNRX) Total Current Liabilities (2018 - 2025)
Volitionrx filings provide 11 years of Total Current Liabilities readings, the most recent being $12.2 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 56.99% to $12.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.2 million, a 56.99% increase, with the full-year FY2025 number at $12.2 million, up 56.99% from a year prior.
- Total Current Liabilities hit $12.2 million in Q4 2025 for Volitionrx, up from $11.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $31.5 million in Q1 2024 to a low of $5.4 million in Q2 2021.
- Median Total Current Liabilities over the past 5 years was $17.0 million (2022), compared with a mean of $15.3 million.
- Biggest five-year swings in Total Current Liabilities: soared 221.42% in 2022 and later crashed 73.73% in 2025.
- Volitionrx's Total Current Liabilities stood at $6.5 million in 2021, then skyrocketed by 166.83% to $17.4 million in 2022, then plummeted by 48.56% to $8.9 million in 2023, then dropped by 12.89% to $7.8 million in 2024, then skyrocketed by 56.99% to $12.2 million in 2025.
- The last three reported values for Total Current Liabilities were $12.2 million (Q4 2025), $11.4 million (Q3 2025), and $9.2 million (Q2 2025) per Business Quant data.